Stratton Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$4.31M Sell
140,583
-32,215
-19% -$1.01M 0.52% 73
2015
Q3
$5.15M Buy
172,798
+46,398
+37% +$1.49M 0.59% 57
2015
Q2
$4.02M Sell
126,400
-7,958
-6% -$259K 0.18% 146
2015
Q1
$4.43M Buy
134,358
+737
+0.6% +$23.4K 0.18% 149
2014
Q4
$3.95M Buy
133,621
+106
+0.1% +$3.04K 0.16% 159
2014
Q3
$3.75M Sell
133,515
-844
-0.6% -$23.7K 0.17% 153
2014
Q2
$3.78M Sell
134,359
-409
-0.3% -$11.7K 0.16% 160
2014
Q1
$4.11M Sell
134,768
-1,264
-0.9% -$37.7K 0.19% 149
2013
Q4
$3.95M Sell
136,032
-5,667
-4% -$165K 0.19% 151
2013
Q3
$3.86M Sell
141,699
-2,305
-2% -$62.7K 0.2% 147
2013
Q2
$3.83M Buy
+144,004
New +$3.98M 0.22% 135

Other funds holding PFE

Stratton Management's PFE Position: Q4 2015 in Review

Stratton Management reduced its Pfizer (PFE) stake by 19% in Q4 2015, selling an estimated $1.01M and leaving 140,583 shares worth $4.31M. The position accounts for 0.52% of the portfolio, ranked #73.

Stratton Management first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $5.15M in Q3 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Stratton Management held 140,583 shares of Pfizer worth $4.31M as of Q4 2015.
  • Stratton Management sold 32,215 Pfizer shares in Q4 2015, an estimated $1.01M.
  • Pfizer made up 0.52% of Stratton Management's portfolio in Q4 2015, its #73 holding.
  • Stratton Management first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
  • Stratton Management's Pfizer position peaked at $5.15M in Q3 2015.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.